Inhibition of release of prostaglandins as an explanation of some of the actions of anti-inflammatory corticosteroids.

PubWeight™: 2.33‹?› | Rank: Top 2%

🔗 View Article (PMID 163980)

Published in Nature on March 27, 1975

Authors

G P Lewis, P J Piper

Articles citing this

Inhibition of arachidonic acid release from cells as the biochemical action of anti-inflammatory corticosteroids. Proc Natl Acad Sci U S A (1976) 3.62

Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat Med (2002) 3.17

Phospholipase A2 activity of guinea-pig isolated perfused lungs: stimulation, and inhibition by anti-inflammatory steroids. Br J Pharmacol (1978) 2.41

Eleventh Gaddum memorial lecture. Lipocortin and the mechanism of action of the glucocorticoids. Br J Pharmacol (1988) 2.38

Acute inflammation. A review. Am J Pathol (1977) 2.06

The effect of systemic prednisolone on arachidonic acid, and prostaglandin E2 and F2 alpha levels in human cutaneous inflammation. Br J Clin Pharmacol (1982) 1.87

Prostaglandin production by macrophages and the effect of anti-inflammatory drugs. Br J Pharmacol (1978) 1.40

Prostaglandin synthetase activity in acute ulcerative colitis: effects of treatment with sulphasalazine, codeine phosphate and prednisolone. Gut (1979) 1.38

Inhibition by glucocorticoids of prostaglandin release from adipose tissue in vitro. Br J Pharmacol (1977) 1.35

Mechanism of inhibition of prostaglandin biosynthesis by hydrocortisone in rat leucocytes. Br J Pharmacol (1979) 1.34

Effect of dexamethasone on in vivo prostanoid production in the rabbit. J Clin Invest (1984) 1.24

Urinary prostaglandin E2 metabolite and gastric cancer risk in the Shanghai women's health study. Cancer Epidemiol Biomarkers Prev (2009) 1.23

Gastrointestinal cytoprotection by prostaglandins. Gut (1979) 1.22

A purified lipocortin shares the anti-inflammatory effect of glucocorticosteroids in vivo in mice. Br J Pharmacol (1989) 1.11

Prostaglandins, nonsteroidal anti-inflammatory agents and eye disease. Trans Am Ophthalmol Soc (1976) 1.09

Background and discovery of lipocortins. Agents Actions (1986) 1.04

In vivo effects of orally administered prednisolone on prostaglandin and leucotriene production in ulcerative colitis. Gut (1987) 1.02

Nicotine inhibits hypoxia- and arachidonate-induced release of prostacyclin-like activity in rabbit hearts. Br J Pharmacol (1980) 0.99

Glucocorticoids increase the responsiveness of cells in culture to prostaglandin E1. Proc Natl Acad Sci U S A (1977) 0.90

Shortening of the bleeding time in rabbits by hydrocortisone caused by inhibition of prostacyclin generation by the vessel wall. J Clin Invest (1979) 0.89

The effects of non-steroidal anti-inflammatory drugs on cholinergic and histamine-induced contractions of guinea-pig isolated ileum. Br J Pharmacol (1977) 0.88

Despite a massive increase in cortisol secretion in women during parturition, there is an equally massive increase in prostaglandin synthesis. A paradox? J Clin Invest (1985) 0.86

Biosynthesis and release of prostaglandins by mast cells. Br J Exp Pathol (1978) 0.86

The effects of glucocorticoids on the distribution and mobilisation of arachidonic acid in fat cell ghosts. Br J Pharmacol (1979) 0.86

The effect of systemically and topically applied drugs on ultraviolet-induced erythema in the rat. Br J Pharmacol (1977) 0.85

Prostaglandin biosynthesis in the human fetal adrenal gland: regulation by glucocorticosteroids. Proc Natl Acad Sci U S A (1982) 0.83

Inflammatory intermediaries in inflammatory bowel disease. Int J Colorectal Dis (1989) 0.82

Proceedings: The effects of anti-inflammatory steroids on levels of prostaglandin in adipose tissue in vitro. Br J Pharmacol (1976) 0.79

Anti-inflammatory action of corticosteroids. Postgrad Med J (1976) 0.79

Influence of hydrocortisone on the modulation of the inflammatory response. Br J Exp Pathol (1978) 0.78

Effects of hydrocortisone and aminophylline on the aggregation of equine platelets in vitro. J Vet Sci (2011) 0.77

Topical hydrocortisone and physiotherapy for nonretractile physiologic phimosis in infants. Pediatr Nephrol (2006) 0.77

Inflammatory models in rats depleted of endogenous precursors of prostaglandins. Agents Actions (1978) 0.76

Proceedings of the British Pharmacological Society. 17th-19th December, 1979: University of London (Institute of Education). Br J Pharmacol (1980) 0.75

Effect of glucocorticoids on vascular reactivity to vasoactive hormones in rat isolated kidney: lack of relationship to prostaglandins. Br J Pharmacol (1984) 0.75

Articles by these authors

Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs. Nature (1969) 13.60

Inactivation of prostaglandins by the lungs. Nature (1970) 4.47

Intracellular enzymes in local lymph as a measure of cellular injury. J Physiol (1967) 4.22

Lymph flow and changes in intracellular enzymes during healing and rejection of rabbit skin grafts. J Physiol (1971) 3.05

Comprehensive drug surveillance. JAMA (1970) 2.92

Structure of slow-reacting substance of anaphylaxis from guinea-pig lung. Nature (1980) 2.69

Changes in the composition of rabbit hind limb lymph after thermal injury. J Physiol (1969) 2.66

Drug rash with ampicillin and other penicillins. Lancet (1969) 2.50

Release of rabbit aorta contracting substance (RCS) and prostaglandins induced by chemical or mechanical stimulation of guinea-pig lungs. Br J Pharmacol (1973) 2.42

Venous thromboembolic disease and ABO blood type. A cooperative study. Lancet (1969) 2.38

Apoptotic photoreceptor degeneration in experimental retinal detachment. Invest Ophthalmol Vis Sci (1995) 2.24

The action of angiotensin and bradykinin on the superior cervical ganglion of the cat. J Physiol (1965) 2.20

Release of mediators of anaphylaxis: inhibition of prostaglandin synthesis and the modification of release of slow reacting substance of anaphylaxis and histamine. Br J Pharmacol (1978) 2.20

Sputum tumour necrosis factor-alpha and leukotriene concentrations in cystic fibrosis. Arch Dis Child (1993) 1.94

Changes in the composition of hind limb lymph after chemical injury. Br J Pharmacol (1970) 1.75

Ampicillin and hetacillin pharmacokinetics in normal and anephric subjects. Clin Pharmacol Ther (1973) 1.74

Comparative effects of inhaled leukotriene C4, leukotriene D4, and histamine in normal human subjects. Thorax (1984) 1.71

Prednisone side-effects and serum-protein levels. A collaborative study. Lancet (1971) 1.67

Fatal drug reactions among medical inpatients. JAMA (1971) 1.64

Contribution of cigarette smoking to cadmium accumulation in man. Lancet (1972) 1.63

The assay of milk-ejecting activity in the lactating rat. Br J Pharmacol Chemother (1967) 1.63

Interaction between the release of SRS-A and of prostaglandins [proceedings]. Br J Pharmacol (1976) 1.63

Induction of nitric oxide synthase in the neo-vasculature of experimental tumours in mice. J Pathol (1993) 1.61

Inhibitors of nitric oxide synthase selectively reduce flow in tumor-associated neovasculature. Br J Pharmacol (1992) 1.61

Release of catecholamines in the guinea-pig by substances involved in anaphylaxis. Nature (1967) 1.59

The action of pharmacologically active substances on the flow and composition of cat hind limb lymph. Br J Pharmacol (1970) 1.58

Effects on smooth muscle preparations of unidentified vasoactiv peptides from intestine and lung. Nature (1970) 1.51

Role of tumor necrosis factor in flavone acetic acid-induced tumor vasculature shutdown. Cancer Res (1990) 1.51

Platelet activating factor does not cause a reproducible increase in bronchial responsiveness in normal man. Clin Exp Allergy (1990) 1.49

Slow-reacting substance of anaphylaxis: purification and characterisation. FEBS Lett (1978) 1.48

The release of spasmogenic substances from human chopped lung tissue and its inhibition. Br J Pharmacol (1973) 1.48

Quantitative in-vivo studies on angiogenesis in a rat sponge model. Br J Exp Pathol (1987) 1.46

Prostacyclin (PGI2) potentiates bradykinin-induced plasma exudation in rabbit skin [proceedings]. Br J Pharmacol (1978) 1.44

Biochemical changes in skin and muscle after thermal injury. Br J Exp Pathol (1970) 1.42

The effect of leukotrienes C4 and D4 on the microvasculature of guinea-pig skin. Prostaglandins (1981) 1.40

The release of rabbit aorta contracting substance (RCS) from chopped lung and its antagonism by anti-inflammatory drugs. Br J Pharmacol (1970) 1.38

Comparison of ampicillin and hetacillin pharmacokinetics in man. J Pharm Sci (1973) 1.35

FGFR1, signaling, and AP-1 expression after retinal detachment: reactive Müller and RPE cells. Invest Ophthalmol Vis Sci (2001) 1.35

Inhibition by glucocorticoids of prostaglandin release from adipose tissue in vitro. Br J Pharmacol (1977) 1.35

Degradation of porstaglandin F2alpha in the human pulmonary circulation. Thorax (1976) 1.34

Doxazosin in the treatment of benign prostatic hyperplasia in normotensive patients: a multicenter study. J Urol (1995) 1.32

Prostaglandin inactivation in guinea-pig lung and its inhibition. Br J Pharmacol (1974) 1.32

Slow reacting substances (SRSs): the structure identification of SRSs from rat basophil leukaemia (RBL-1) cells. Prostaglandins (1980) 1.32

Proliferative vitreoretinopathy-developments in adjunctive treatment and retinal pathology. Eye (Lond) (2002) 1.32

Antagonism by fenamates and like-acting drugs of bronchoconstriction induced by bradykinin or antigen in the guinea-pig. Br J Pharmacol (1968) 1.32

Intracellular enzymes and protein synthesis in rabbit skin after thermal injury. Br J Pharmacol (1971) 1.31

The mechanism of the inhibitory action of adrenaline on the mammary gland. Br J Pharmacol Chemother (1967) 1.29

Children's incremental dental care program: an overview of the southeast Tennessee-northwest Georgia project. J Am Dent Assoc (1974) 1.27

Cadmium accumulation im man: influence of smoking, occupation, alcoholic habit and disease. J Chronic Dis (1972) 1.27

Intracellular enzymes and kinin enzymes in synovial fluid in joint diseases. Origin and relation to disease category. Ann Rheum Dis (1969) 1.27

Intracellular enzymes in local lymph after chemical injury. Br J Pharmacol (1970) 1.26

Comparative bioassay of prostaglandin E2 and its three pulmonary metabolites. Br J Pharmacol (1975) 1.25

Formation and actions of leukotrienes. Physiol Rev (1984) 1.24

The mechanism of action of leukotrienes C4 and D4 in guinea-pig isolated perfused lung and parenchymal strips of guinea pig, rabbit and rat. Prostaglandins (1981) 1.22

Intraretinal proliferation induced by retinal detachment. Invest Ophthalmol Vis Sci (1991) 1.21

Comparative studies on immunologically and non-immunologically produced slow-reacting substances from man, guinea-pig and rat. Br J Pharmacol (1979) 1.21

Coronary vasoconstriction in the rat, isolated perfused heart induced by platelet-activating factor is mediated by leukotriene C4. Br J Pharmacol (1986) 1.20

Proceedings: The effect of sulphinpyrazone, sodium aspirin and oxprenolol on the formation of arterial platelet thrombi. Br J Pharmacol (1975) 1.20

Proceedings: The pro-inflammatory activity of E-, A-, D- and F-type prostaglandins and analogues 16, 16-dimethyl-PGE2 and (15S)-15-methyl-PGE2 in rabbit skin; the relationship between potentiation of plasma exudation and local blood flow changes. Br J Pharmacol (1976) 1.20

Computer analysis of epidemiologic data on effect of drugs on hospital patients. Public Health Rep (1969) 1.19

Mechanisms of inhibition of phospholipase A2. Biochem Pharmacol (1980) 1.18

The release of prostaglandins and thromboxanes from guinea-pig lung by slow reacting substance of anaphylaxis, and its inhibition. Br J Pharmacol (1978) 1.18

Lymph flow and lymph protein concentration in the skin and muscle of the rabbit hind limb. J Physiol (1973) 1.18

Stimulation of arachidonic acid metabolism and generation of thromboxane A2 by leukotrienes B4, C4 and D4 in guinea-pig lung in vitro. Br J Pharmacol (1982) 1.17

Lipid mediators in cystic fibrosis and chronic obstructive pulmonary disease. Am Rev Respir Dis (1987) 1.17

The mobilization of free fatty acids from rabbit adipose tissue in situ. Br J Pharmacol (1968) 1.14

The mechanism of functional vasodilatation in rabbit epigastric adipose tissue. J Physiol (1970) 1.12

The relationship between functional vasodilatation in adipose tissue and prostaglandin. Br J Pharmacol (1970) 1.12

Thin-layer acrylamide gel electrophoresis. J Clin Pathol (1970) 1.11

Centrilobular emphysema experimentally induced by cadmium chloride aerosol. Am Rev Respir Dis (1973) 1.10

Leukotrienes in the sputum and urine of cystic fibrosis children. Br J Clin Pharmacol (1990) 1.10

The action of chemically pure SRS-A on the microcirculation in vivo. Prostaglandins (1980) 1.09

The epidemiology o digoxin. A study in three Boston hospitals. J Chronic Dis (1969) 1.09

The actions of leukotrienes C4 and D4 on guinea-pig isolated hearts. Br J Pharmacol (1982) 1.07

Proceedings: A new approach for studying the anti-rheumatic activity of indomethacin using the homograft reaction as a model for chronic immunologically-mediated inflammation. Br J Pharmacol (1974) 1.07

Proceedings: Measurement of changes in the microvasculature. Br J Pharmacol (1976) 1.07

ADP metabolism in vascular tissue, a possible thrombo-regulatory mechanism. Thromb Res (1979) 1.07

A membrane-bound enzyme in rabbit aorta capable of inhibiting adenosine-diphosphate-induced platelet aggregation. Lancet (1977) 1.06

The Liang Bua faunal remains: a 95k.yr. sequence from Flores, East Indonesia. J Hum Evol (2008) 1.06

Pharmacology of leukotrienes. Br Med Bull (1983) 1.05

Further studies on the actions of peptides on the superior cervical ganglion and suprarenal medulla. Br J Pharmacol Chemother (1966) 1.05

Potentiation of bradykinin-induced exudation following intradermal injection of particulate or colloidal materials in the rabbit: evidence for prostaglandin release and action in inflammation [proceedings]. Br J Pharmacol (1977) 1.05

Recovery of photoreceptor outer segment length and analysis of membrane assembly rates in regenerating primate photoreceptor outer segments. Invest Ophthalmol Vis Sci (1993) 1.04

Immunoregulatory activity of metabolites of arachidonic acid and their role in inflammation. Br Med Bull (1983) 1.04

Slow-reacting substance of anaphylaxis: studies on purification and characterisation. Agents Actions Suppl (1979) 1.03

Release of vaso-active substances from lungs by injection of particles. Br J Pharmacol (1970) 1.02

Microvascular responses produced by the prostaglandin endoperoxide PGG2 in vivo [proceedings]. Br J Pharmacol (1977) 1.02

The role of the epithelium in modulating the responses of guinea-pig trachea induced by bradykinin in vitro. Br J Pharmacol (1990) 1.01

Inhibition of the pulmonary inactivation of prostaglandins in vivo by di-4-phloretin phosphate. Br J Pharmacol (1975) 1.00

Induction of cyclo-oxygenase by interleukin-1 in rheumatoid synovial cells. FEBS Lett (1987) 1.00

Infected pancreatic fluid collections: percutaneous catheter drainage. Radiology (1988) 1.00

Detection of sputum eicosanoids in cystic fibrosis and in normal saliva by bioassay and radioimmunoassay. Br J Clin Pharmacol (1987) 0.99

Cadmium content of cigarettes. Lancet (1969) 0.98

The effect of histamine antagonists on antigen-induced contractions of sensitized human bronchus in vitro [proceedings]. Br J Pharmacol (1977) 0.98

Nonoperative versus operative treatment of obstructive jaundice in pancreatic cancer: cost and survival analysis. Am J Gastroenterol (1988) 0.98

Factors influencing blood supply in wound granuloma quantitated by a new in vivo technique. Cancer Res (1989) 0.98

Use of the MIB-1 antibody for detecting proliferating cells in the retina. Invest Ophthalmol Vis Sci (1995) 0.97

Neutrophil stimulation by recombinant cytokines and a factor produced by IL-1-treated human synovial cell cultures. Immunology (1988) 0.96